Yes, drug R&D is difficult, costly and risky. But these factors don’t really justify a high price. Value does.
Subscribe to:
Post Comments (Atom)
< + > Digital Twins with Unlearn – Life Sciences Today Podcast Episode 26
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Smith, Co-...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
Training artificial intelligence models on more diverse image and data sets can augment decision making, overcome knowledge gaps, and promot...
No comments:
Post a Comment